Edit |   |
---|---|
Antigenic Specificity | TGFB1, Human (Metelimumab biosimilar) |
Clone | Metelimumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human TGFB1 Recombinant Antibody. Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that neutralizes TGF beta 1 which had been chosen for further development for the treatment of diffuse cutaneous systemic sclerosis, also known as scleroderma. It was dropped from further development in favour of fresolimumab, which was being developed by Genzyme as of 2006. |
Immunogen | n/a |
Other Names | Anti-TGFB1 Recombinant Antibody, Research Grade Metelimumab, Anti-Human TGFB1 Recombinant Antibody, CAT-192, Antibody Drug Analogues, Monoclonal Antibody, YR1121, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 272780-74-2 |
Catalog # | YR1121 |
Price | please inquire |
Order / More Info | TGFB1, Human (Metelimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |